Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Risk of Pneumonitis with Immune Checkpoint Inhibitors in Hodgkin's Lymphoma and Other Hematologic Malignancies: A Retrospective Review from Pharmacovigilance

Ugochi Ebinama, Ajay Sheshadiri, Sairah Ahmed, Hun Ju Lee, Meng Liu, Swaminathan Padmanabhan Iyer

Blood (2022) 140 (Supplement 1): 5183–5184.

https://doi.org/10.1182/blood-2022-165698

Published: 2022

Journal Articles

Primary Analysis of a Pilot Study of Prophylactic Anakinra to Mitigate CAR T Cell-Associated Toxicity in Patients with Relapsed or Refractory Large B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 7493–7495.

https://doi.org/10.1182/blood-2022-157448

Published: 2022

Journal Articles

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Blood (2022) 140 (Supplement 1): 415–416.

https://doi.org/10.1182/blood-2022-156125

Published: 2022

Journal Articles

Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy

Xubin Li, Qing Deng, Jared Henderson, Grace Watson, Laurel Deaton, Taylor Cain, Luis Fayad, Swaminathan Padmanabhan Iyer, Fredrick B. Hagemeister, Loretta J. Nastoupil, Nathan H. Fowler, Jason Westin, Raphael Steiner, Ranjit Nair, Sairah Ahmed, Gheath Alatrash, Sattva S. Neelapu, Paolo Strati, Michael R Green

Blood (2022) 140 (Supplement 1): 4502–4503.

https://doi.org/10.1182/blood-2022-166308

Published: 2022

Journal Articles

Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections

Rishab Prakash, James Long, Paul Edelkamp, Jr., Mark Knafl, Sairah Ahmed, Fareed Khawaja, Loretta J. Nastoupil, Joanna-Grace Manzano, Victor Mulanovich, Sabitha Prabhakaran, Andrew Futreal, Scott E Woodman, Swaminathan Padmanabhan Iyer

Blood (2022) 140 (Supplement 1): 10907–10908.

https://doi.org/10.1182/blood-2022-169853

Published: 2022

Journal Articles

Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.

Blood (2022) 140 (Supplement 1): 12005–12007.

https://doi.org/10.1182/blood-2022-170750

Published: 2022

Journal Articles

Prognostic Significance of Cutaneous Angioimmunoblastic T-Cell Lymphoma: Correlation of Clinical, Histologic and Immunophenotypic Features with Response

Christopher N Nguyen, Rishab Prakash, Madeleine Duvic, Meghan Heberton, Julia Dai, Ranjit Nair, Luis Enrique Malpica Castillo, Carlos Torres Cabala, Lei Feng, Swaminathan Padmanabhan Iyer, Auris Huen

Blood (2022) 140 (Supplement 1): 9406–9407.

https://doi.org/10.1182/blood-2022-163810

Published: 2022

Journal Articles

CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL

Blood (2022) 140 (Supplement 1): 3800–3802.

https://doi.org/10.1182/blood-2022-171120

Published: 2022

Journal Articles

Pharmacological Inhibitory Effect of Imetelstat, a Novel Human Telomerase Inhibitor in Diffuse Large B-Cell Lymphoma and Peripheral T-Cell Lymphoma

Akanksha Aradhya, Nitin Agarwal, Swaminathan Padmanabhan Iyer, Fei Huang, Francisco Vega

Blood (2022) 140 (Supplement 1): 11932–11933.

https://doi.org/10.1182/blood-2022-162767

Published: 2022

Journal Articles

Outcomes of Patients with Extranodal Natural Killer/T-Cell Lymphoma: Single Institution Series

Blood (2021) 138 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2021-154347

Published: 2021

Journal Articles

Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-2 Clinical Trial

Blood (2021) 138 (Supplement 1): 3525.

https://doi.org/10.1182/blood-2021-153390

Published: 2021

Journal Articles

Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma

Blood (2021) 138 (Supplement 1): 2463.

https://doi.org/10.1182/blood-2021-150798

Published: 2021

Journal Articles

Outcome of Patients with T- Cell Histiocyte Rich B Cell Lymphoma: Single Institution Series

Blood (2021) 138 (Supplement 1): 1448.

https://doi.org/10.1182/blood-2021-154035

Published: 2021

Journal Articles

CD70 Expression in Mature T-Cell Lymphomas

Mario L. Marques-Piubelli, Luisa Solis Soto, Swaminathan Padmanabhan Iyer, Jason Sagert, Minh Thu Pham, Kimberly Tipton, Wei Lu, Khaja B Khan, Leticia G Hamana Zorrilla, Jennifer R Chapman, Beenu Thakral, Jie Xu, Roberto N. Miranda, Kristofer Jennings, Francisco Vega

Blood (2021) 138 (Supplement 1): 4493.

https://doi.org/10.1182/blood-2021-146990

Published: 2021

Journal Articles

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

Blood (2019) 133 (26): 2765–2775.

https://doi.org/10.1182/blood-2019-01-896290

Published: 2019

Includes: Supplemental data

Journal Articles

Systematic Drug Repositioning By Integrating Transcriptome and Historical Clinical Data, Identification of Digoxin As a Novel Drug Reposition Candidate for High-Risk Myelodysplastic Syndromes

Huojun Cao, Zheng Yin, PhD, Shenyi Chen, Timothy Liu, Jiyong Liu, Yaping Hu, Hong Zhao, Lawrence Rice, MD, Swaminathan Padmanabhan Iyer, MD, Stephen Wong

Blood (2015) 126 (23): 4118.

https://doi.org/10.1182/blood.V126.23.4118.4118

Published: 2015

Journal Articles

Staphylococcus Species Leads the Eskape Infections in Various Hematological Malignancies

Purnima Sravanti Teegavarapu, MD, Mamta Puppala, MSc, Sai Ravi Pingali, MD, Asmita Patel, Ibrahim Ibrahim, MD, Akash Mukherjee, MD, Lawrence Rice, MD, Swaminathan Padmanabhan Iyer, MD

Blood (2015) 126 (23): 4623.

https://doi.org/10.1182/blood.V126.23.4623.4623

Published: 2015

Journal Articles

Leukapheresis Reduces 4-Week Mortality in Leukemia Patient with Hyperleukocytosis-a Retrospective Study from a Tertiary Center

Nan Xinyu, Srivastava Pallavi, Mamta Puppala, MSc, Sai Ravi Pingali, MD, Ibrahim Ibrahim, Lawrence Rice, MD, Alexandria T. Phan, MD, Swaminathan Padmanabhan Iyer, MD

Blood (2015) 126 (23): 3782.

https://doi.org/10.1182/blood.V126.23.3782.3782

Published: 2015

Journal Articles

Mechanistic Role of HEXIM1 Induction in BRD4-Antagonist Mediated Growth Inhibition, Differentiation and in Vivo Lethal Activity Against Human AML Blast Progenitor Cells

Santhana G. T. Devaraj, PhD, Warren Fiskus, PhD, Bhavin Shah, Sunil Sharma, Jun Qi, PhD, Baohua Sun, MD PhD, Saikat Saha, PhD, Swaminathan Padmanabhan Iyer, MD, Youli Zu, MD PhD, James Bradner, MD, Kapil N. Bhalla, MD

Blood (2014) 124 (21): 3534.

https://doi.org/10.1182/blood.V124.21.3534.3534

Published: 2014

Journal Articles

Neighborhood Death Rate: A Big-Data Based Health Informatics Pipeline Helps Identify Factors Impacting Clinical Outcomes and Cost Effectiveness in Acute Myeloid Leukemia Patients

Zheng Yin, Anish S Konde, MB BS, Mamta Puppala, MS, Pallavi Srivastava, Wong Stephen, Lawrence Rice, MD, Swaminathan Padmanabhan Iyer, MD

Blood (2014) 124 (21): 2625.

https://doi.org/10.1182/blood.V124.21.2625.2625

Published: 2014

NARROW

Risk of Pneumonitis with Immune Checkpoint Inhibitors in Hodgkin's Lymphoma and Other Hematologic Malignancies: A Retrospective Review from Pharmacovigilance

Primary Analysis of a Pilot Study of Prophylactic Anakinra to Mitigate CAR T Cell-Associated Toxicity in Patients with Relapsed or Refractory Large B-Cell Lymphoma

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy

Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections

Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.

Prognostic Significance of Cutaneous Angioimmunoblastic T-Cell Lymphoma: Correlation of Clinical, Histologic and Immunophenotypic Features with Response

CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL

Pharmacological Inhibitory Effect of Imetelstat, a Novel Human Telomerase Inhibitor in Diffuse Large B-Cell Lymphoma and Peripheral T-Cell Lymphoma

Outcomes of Patients with Extranodal Natural Killer/T-Cell Lymphoma: Single Institution Series

Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-2 Clinical Trial

Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma

Outcome of Patients with T- Cell Histiocyte Rich B Cell Lymphoma: Single Institution Series

CD70 Expression in Mature T-Cell Lymphomas

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

Systematic Drug Repositioning By Integrating Transcriptome and Historical Clinical Data, Identification of Digoxin As a Novel Drug Reposition Candidate for High-Risk Myelodysplastic Syndromes

Staphylococcus Species Leads the Eskape Infections in Various Hematological Malignancies

Leukapheresis Reduces 4-Week Mortality in Leukemia Patient with Hyperleukocytosis-a Retrospective Study from a Tertiary Center

Mechanistic Role of HEXIM1 Induction in BRD4-Antagonist Mediated Growth Inhibition, Differentiation and in Vivo Lethal Activity Against Human AML Blast Progenitor Cells

Neighborhood Death Rate: A Big-Data Based Health Informatics Pipeline Helps Identify Factors Impacting Clinical Outcomes and Cost Effectiveness in Acute Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only